Low junctional adhesion molecule-A expression is associated with an epithelial to mesenchymal transition and poorer outcomes in high-grade serous carcinoma of uterine adnexa
- 1 November 2020
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 33 (11), 2361-2377
- https://doi.org/10.1038/s41379-020-0586-0
Abstract
No abstract availableFunding Information
- Terry Fox Research Institute (Selective Therapy Program)
- Fonds de recherche du Québec-Santé
- Ovarian Cancer Canada’s Teal Heart Scholarship
- Fonds de Recherche du Québec-Santé Réseau de Recherche sur le cancer
This publication has 58 references indexed in Scilit:
- Overexpression of JAM-A in Non-Small Cell Lung Cancer Correlates with Tumor ProgressionPLOS ONE, 2013
- Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancerEMBO Molecular Medicine, 2013
- Prognostically relevant gene signatures of high-grade serous ovarian carcinomaJCI Insight, 2012
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- aPKC phosphorylates JAM-A at Ser285 to promote cell contact maturation and tight junction formationThe Journal of cell biology, 2012
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- Abrogation of Junctional Adhesion Molecule-A Expression Induces Cell Apoptosis and Reduces Breast Cancer ProgressionPLOS ONE, 2011
- Structural determinants of Junctional Adhesion Molecule A (JAM-A) function and mechanisms of intracellular signalingCurrent Opinion in Cell Biology, 2009
- Downregulation of junctional adhesion molecule-A is involved in the progression of clear cell renal cell carcinomaBiochemical and Biophysical Research Communications, 2009
- JAM-A promotes neutrophil chemotaxis by controlling integrin internalization and recyclingJournal of Cell Science, 2009